Align Technology, Inc. (ALGN) Shares Bought by United Services Automobile Association
United Services Automobile Association grew its stake in Align Technology, Inc. (NASDAQ:ALGN) by 1.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 59,529 shares of the medical equipment provider’s stock after purchasing an additional 653 shares during the quarter. United Services Automobile Association owned approximately 0.07% of Align Technology worth $23,289,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in ALGN. Stevens Capital Management LP purchased a new position in shares of Align Technology in the third quarter worth about $5,167,000. Franklin Resources Inc. lifted its stake in shares of Align Technology by 36.0% in the third quarter. Franklin Resources Inc. now owns 72,528 shares of the medical equipment provider’s stock worth $28,374,000 after buying an additional 19,215 shares in the last quarter. Crosspoint Capital Strategies LLC purchased a new position in shares of Align Technology in the third quarter worth about $1,606,000. Glassman Wealth Services lifted its stake in shares of Align Technology by 1,459.1% in the third quarter. Glassman Wealth Services now owns 1,793 shares of the medical equipment provider’s stock worth $701,000 after buying an additional 1,678 shares in the last quarter. Finally, Compagnie Lombard Odier SCmA lifted its stake in shares of Align Technology by 76.7% in the third quarter. Compagnie Lombard Odier SCmA now owns 530 shares of the medical equipment provider’s stock worth $208,000 after buying an additional 230 shares in the last quarter. Institutional investors and hedge funds own 78.03% of the company’s stock.
In other Align Technology news, SVP Sreelakshmi Kolli sold 5,000 shares of Align Technology stock in a transaction dated Tuesday, November 27th. The shares were sold at an average price of $223.15, for a total transaction of $1,115,750.00. Following the completion of the sale, the senior vice president now directly owns 27,180 shares in the company, valued at $6,065,217. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Joseph Lacob sold 10,000 shares of Align Technology stock in a transaction dated Friday, November 30th. The shares were sold at an average price of $231.82, for a total transaction of $2,318,200.00. The disclosure for this sale can be found here. Insiders have sold 23,764 shares of company stock worth $5,427,059 over the last ninety days. 1.40% of the stock is owned by insiders.
Shares of ALGN stock opened at $220.95 on Wednesday. Align Technology, Inc. has a 12 month low of $188.57 and a 12 month high of $398.88. The stock has a market cap of $18.39 billion, a price-to-earnings ratio of 56.80, a PEG ratio of 2.05 and a beta of 2.05.
Align Technology (NASDAQ:ALGN) last issued its earnings results on Wednesday, October 24th. The medical equipment provider reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.05. Align Technology had a net margin of 16.89% and a return on equity of 34.09%. The company had revenue of $505.30 million for the quarter, compared to the consensus estimate of $503.14 million. During the same period in the previous year, the firm earned $1.01 earnings per share. Align Technology’s quarterly revenue was up 31.1% compared to the same quarter last year. As a group, equities analysts predict that Align Technology, Inc. will post 4.87 EPS for the current fiscal year.
Align Technology Company Profile
Align Technology, Inc designs, manufactures, and markets a system of clear aligner therapy, intraoral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services. The company's Clear Aligner segment offers Invisalign Full, a treatment used for a range of malocclusion; Invisalign Teen treatment that addresses orthodontic needs of teenage patients, such as compliance indicators, compensation for tooth eruption, and six free single arch replacement aligners; and Invisalign Assist treatment for anterior alignment and aesthetically-oriented cases.
Featured Story: Bear Market – How and Why They Occur
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN).
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.